/stocks — the workspaceLOADING
PTC THERAPEUTICS, INC. (PTCT) is a pharmaceutical preparations company. Piotroski F-Score 6/8. 14 insider Form 4 filings in the last 90 days. Next earnings projected around 2026-08-06 from PTCT's year-over-year reporting pattern (not yet company-confirmed). Fundamentals from SEC filings; prices are end-of-day.
EOD daily bars · delayed, not real-time · data: DatabentoCharting by TradingView Lightweight Charts™
XBRL company facts, SEC EDGAR. TTM = last four reported quarters. Valuation ratios arrive with a price source — we don't fake quotes.
FY ending 2025-12-31 vs 2024-12-31. original 1968 formula; calibrated on manufacturers, read financials/REITs with care
A plain-English read on PTCT plus an auto-SWOT — built from PTCT's SEC filings and market data, every point cited, nothing invented. Educational, not investment advice.
Four AI analysts — a bull, a bear, a risk manager, and a PM — debate PTCT using only the SEC-filing and market facts below. Every point cites its evidence; nothing is invented. This is educational research, not investment advice.
Educational only — not financial advice. Data from SEC EDGAR public filings; no live market data is shown. Figures reflect the company's own reported XBRL facts and may lag.
| Jefferies Financial Group | $92.3M | 0.6% of portfolio |
| Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER | SELL | $222K | view → |
| Smith Mary L.Director | SELL | $1.4M | view → |
| Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER | SELL | $4.1M | view → |
| Boulding Mark ElliottEXEC. VP AND CLO | SELL | $432K | view → |
| Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER | SELL | $693K | view → |
| Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER | SELL | $2.3M | view → |
| Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER | SELL | $1.9M | view → |
| Boulding Mark ElliottEXEC. VP AND CLO | SELL | $823K | view → |
Projected from PTCT's own SEC 8-K filing history — the year-over-year reporting pattern (~50% land the exact day, ~90% within a week). No analyst estimates, no scraped calendars, nothing invented. It upgrades to a confirmed date + time the moment PTCT files its announcement.
PTCT has rallied after 5 of its last 8 earnings reports.
Earnings reactions have been moderate.
PTCT has traded higher after most recent earnings releases.
The average is inflated by its most volatile prints (+10.7% and -11.6%).
A more typical earnings reaction has been approximately ±5.3%.
Realized close-to-close history only — no options-implied move, no analyst estimates.
| Reported | Close-to-close |
|---|---|
| 2026-05-07 | +10.7% |
| 2026-02-19 | +2.5% |
| 2026-01-12 | -2.7% |
| 2025-11-04 | +5.7% |
| 2025-08-07 | -11.6% |
| 2025-05-06 | +0.3% |
| 2025-02-27 |
Earnings dates are the company's 8-K Item 2.02 filings (SEC). Reactions from Databento EOD.
| +8.4% |
| 2025-01-13 | -4.8% |